<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Essential <z:hpo ids='HP_0001894'>thrombocytosis</z:hpo> (ET) is an uncommon pediatric <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorder</z:e> that can result in thrombotic complications, including cerebral venous sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> (CVST) </plain></SENT>
<SENT sid="1" pm="."><plain>Although CVST associated with ET is exceedingly rare, it can be devastating to the patient </plain></SENT>
<SENT sid="2" pm="."><plain>We here report a pediatric case of CVST associated with ET </plain></SENT>
<SENT sid="3" pm="."><plain>The patient was treated with <z:chebi fb="0" ids="44423">hydroxyurea</z:chebi> and <z:chebi fb="8" ids="10033">warfarin</z:chebi>, which was later replaced by low-dose aspirin </plain></SENT>
<SENT sid="4" pm="."><plain>Platelet counts were well controlled after 16 months of follow-up, and no further thrombotic events occurred </plain></SENT>
<SENT sid="5" pm="."><plain>Mucositis was the main adverse effect of treatment </plain></SENT>
</text></document>